ANI Pharmaceuticals Announces the FDA Approval and Launch of Indomethacin Oral Suspension, USP

January 19, 2024

https://www.globenewswire.com/news-release/2024/01/16/2809672/0/en/ANI-Pharmaceuticals-Announces-the-FDA-Approval-and-Launch-of-Indomethacin-Oral-Suspension-USP.html

BAUDETTE, Minn., Jan. 16, 2024 (GLOBE NEWSWIRE) —  ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq:ANIP) today announced that it received U.S. Food and Drug Administration (FDA) approval for the Abbreviated New Drug Application (ANDA) for Indomethacin Oral Suspension (OS), USP.

Read more at globenewswire.com

Related news for (ANIP)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.